Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials

AbstractContext Berberine is a potential drug that can effectively treat cardiovascular diseases, including premature ventricular contractions (PVCs).Objective This study was conducted to assess the efficacy and safety of berberine for PVCs.Methods The literature was searched using PubMed, Cochrane...

Full description

Bibliographic Details
Main Authors: Meng Qiao, Chao Lei, Chaoren Tan, Cuncun Lu, Zijia Chen, Qiang Zhang, Zhifei Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Pharmaceutical Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2023.2248167
_version_ 1797234821478481920
author Meng Qiao
Chao Lei
Chaoren Tan
Cuncun Lu
Zijia Chen
Qiang Zhang
Zhifei Wang
author_facet Meng Qiao
Chao Lei
Chaoren Tan
Cuncun Lu
Zijia Chen
Qiang Zhang
Zhifei Wang
author_sort Meng Qiao
collection DOAJ
description AbstractContext Berberine is a potential drug that can effectively treat cardiovascular diseases, including premature ventricular contractions (PVCs).Objective This study was conducted to assess the efficacy and safety of berberine for PVCs.Methods The literature was searched using PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang, and Chinese Biomedical Literature Database (CBM) for randomized controlled trials (RCTs) from inception to October 1, 2022. The risk of bias was assessed using the Revised Cochrane risk-of-bias tool for randomized trials, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to assess the quality of evidence.Results Ten RCTs with 896 participants were included in the meta-analysis. The results showed that compared to antiarrhythmic drugs (AD), berberine (BE) combined with AD had a higher effective rate (RR = 1.26; 95% CI:1.12, 1.42; p = 0.0001) with no significant incidence of adverse reactions (RR = 0.93; 95% CI:0.33, 2.57; p = 0.88), and BE alone had no significant difference in effective rate (RR = 0.91; 95% CI:0.77, 1.07; p = 0.23), and a lower incidence of adverse reactions (RR = 0.38; 95% CI:0.15, 0.97; p = 0.04) and recurrence rate (RR = 0.40; 95% CI:0.18, 0.88; p = 0.02).Conclusions The results suggest that BE is an effective and safe adjunctive method for PVCs. In addition, BE is recommended for patients with PVCs who had severe adverse reactions after administrating AD as an alternative therapy.
first_indexed 2024-03-09T00:08:56Z
format Article
id doaj.art-363eed86ce984557a9228f66f543aecf
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-24T16:38:09Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-363eed86ce984557a9228f66f543aecf2024-03-29T11:10:26ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162023-12-016111474148310.1080/13880209.2023.2248167Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trialsMeng Qiao0Chao Lei1Chaoren Tan2Cuncun Lu3Zijia Chen4Qiang Zhang5Zhifei Wang6Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, PR ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, PR ChinaInstitute of Acupuncture and Moxibustion, China Academy of Chinese Medical Science, Beijing, PR ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, PR ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, PR ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, PR ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, PR ChinaAbstractContext Berberine is a potential drug that can effectively treat cardiovascular diseases, including premature ventricular contractions (PVCs).Objective This study was conducted to assess the efficacy and safety of berberine for PVCs.Methods The literature was searched using PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang, and Chinese Biomedical Literature Database (CBM) for randomized controlled trials (RCTs) from inception to October 1, 2022. The risk of bias was assessed using the Revised Cochrane risk-of-bias tool for randomized trials, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to assess the quality of evidence.Results Ten RCTs with 896 participants were included in the meta-analysis. The results showed that compared to antiarrhythmic drugs (AD), berberine (BE) combined with AD had a higher effective rate (RR = 1.26; 95% CI:1.12, 1.42; p = 0.0001) with no significant incidence of adverse reactions (RR = 0.93; 95% CI:0.33, 2.57; p = 0.88), and BE alone had no significant difference in effective rate (RR = 0.91; 95% CI:0.77, 1.07; p = 0.23), and a lower incidence of adverse reactions (RR = 0.38; 95% CI:0.15, 0.97; p = 0.04) and recurrence rate (RR = 0.40; 95% CI:0.18, 0.88; p = 0.02).Conclusions The results suggest that BE is an effective and safe adjunctive method for PVCs. In addition, BE is recommended for patients with PVCs who had severe adverse reactions after administrating AD as an alternative therapy.https://www.tandfonline.com/doi/10.1080/13880209.2023.2248167Coptis chinensistraditional Chinese medicinecomplementary alternative medicineantiarrhythmic drugs
spellingShingle Meng Qiao
Chao Lei
Chaoren Tan
Cuncun Lu
Zijia Chen
Qiang Zhang
Zhifei Wang
Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
Pharmaceutical Biology
Coptis chinensis
traditional Chinese medicine
complementary alternative medicine
antiarrhythmic drugs
title Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
title_full Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
title_fullStr Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
title_full_unstemmed Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
title_short Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
title_sort efficacy and safety of berberine for premature ventricular contractions a meta analysis and systematic review of randomized controlled trials
topic Coptis chinensis
traditional Chinese medicine
complementary alternative medicine
antiarrhythmic drugs
url https://www.tandfonline.com/doi/10.1080/13880209.2023.2248167
work_keys_str_mv AT mengqiao efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials
AT chaolei efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials
AT chaorentan efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials
AT cuncunlu efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials
AT zijiachen efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials
AT qiangzhang efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials
AT zhifeiwang efficacyandsafetyofberberineforprematureventricularcontractionsametaanalysisandsystematicreviewofrandomizedcontrolledtrials